|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
48,973,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Arcellx is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Co.'s D-Domain powered autologous and allogeneic Chimeric Antigen Receptor T cells (CAR-Ts), including classical single infusion CAR-Ts product candidate, CART-ddBCMA, is for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM), defined as patients with either minimal response or disease progression within 60 days of last treatment. Co. is also developing its ARC-SparX programs, ACLX-001 in r/r MM and ACLX-002 and ACLX-003 in r/r acute myeloid leukemia and myelodysplastic syndrome.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
312,500 |
| Total Buy Value |
$0 |
$0 |
$0 |
$5,000,000 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
617,559 |
1,335,183 |
1,699,207 |
3,456,214 |
| Total Sell Value |
$42,966,010 |
$79,309,104 |
$94,464,355 |
$172,412,706 |
| Total People Sold |
5 |
5 |
5 |
10 |
| Total Sell Transactions |
8 |
19 |
26 |
45 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Sonsini Peter W. |
10% Owner |
– – • |
2022-12-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,030,000) |
0 |
|
- |
|
| Florence Anthony A. Jr. |
10% Owner |
– – • |
2022-12-20 |
4 |
A |
$0.00 |
$0 |
I/I |
30,179 |
179 |
|
- |
|
| Florence Anthony A. Jr. |
10% Owner |
– – • |
2022-12-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,030,000) |
0 |
|
- |
|
| New Enterprise Associates 15, L.p. |
10% Owner |
– – • |
2022-12-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,000,000) |
4,745,262 |
|
- |
|
| Nea 15 Gp, Llc |
10% Owner |
– – • |
2022-12-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(30,000) |
0 |
|
- |
|
| Nea 15 Gp, Llc |
10% Owner |
– – • |
2022-12-20 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
30,000 |
|
- |
|
| Nea 15 Gp, Llc |
10% Owner |
– – • |
2022-12-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,000,000) |
4,745,262 |
|
- |
|
| Baskett Forest |
10% Owner |
– – • |
2022-12-20 |
4 |
A |
$0.00 |
$0 |
I/I |
31,628 |
1,628 |
|
- |
|
| Baskett Forest |
10% Owner |
– – • |
2022-12-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,030,000) |
0 |
|
- |
|
| Behbahani Ali |
Director |
– • – |
2022-12-20 |
4 |
A |
$0.00 |
$0 |
D/D |
226 |
226 |
|
- |
|
| Behbahani Ali |
Director |
– • – |
2022-12-20 |
4 |
A |
$0.00 |
$0 |
I/I |
57 |
57 |
|
- |
|
| Heery Christopher |
Chief Medical Officer |
• – – |
2022-12-13 |
4 |
AS |
$30.03 |
$375,320 |
D/D |
(12,500) |
0 |
|
- |
|
| Heery Christopher |
Chief Medical Officer |
• – – |
2022-12-13 |
4 |
OE |
$6.28 |
$143,900 |
D/D |
12,500 |
12,500 |
|
- |
|
| Baskett Forest |
10% Owner |
– – • |
2022-06-21 |
4 |
B |
$16.00 |
$5,000,000 |
D/D |
312,500 |
6,745,262 |
2.45 |
- |
|
| Sr One Co-Invest Ii Manager, Llc |
10% Owner |
– – • |
2022-02-08 |
4 |
B |
$15.00 |
$25,000,005 |
I/I |
1,666,667 |
2,033,196 |
1.5 |
- |
|
| Sr One Co-Invest Ii Manager, Llc |
10% Owner |
– – • |
2022-02-08 |
4 |
A |
$0.00 |
$0 |
I/I |
3,833,340 |
433,196 |
|
- |
|
| Carroll Jill |
Director |
– • – |
2022-02-08 |
4 |
B |
$15.00 |
$25,000,005 |
I/I |
1,666,667 |
2,033,196 |
2.1 |
- |
|
| Carroll Jill |
Director |
– • – |
2022-02-08 |
4 |
A |
$0.00 |
$0 |
I/I |
3,833,340 |
433,196 |
|
- |
|
| Sonsini Peter W. |
10% Owner |
– – • |
2022-02-08 |
4 |
B |
$15.00 |
$23,749,995 |
D/D |
1,583,333 |
6,432,762 |
2.45 |
- |
|
| Sonsini Peter W. |
10% Owner |
– – • |
2022-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,849,429 |
4,849,429 |
|
- |
|
| Novo A/s |
10% Owner |
– – • |
2022-02-08 |
4 |
B |
$15.00 |
$12,499,995 |
D/D |
833,333 |
4,016,878 |
2.45 |
- |
|
| Novo A/s |
10% Owner |
– – • |
2022-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,183,545 |
3,183,545 |
|
- |
|
| Williams Lewis T |
Director |
– • – |
2022-02-08 |
4 |
A |
$0.00 |
$0 |
I/I |
2,095,114 |
2,095,114 |
|
- |
|
| Lubner David Charles |
Director |
– • – |
2022-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
21,659 |
21,659 |
|
- |
|
99 Records found
|
|
Page 4 of 4 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
